{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["14(4)"],"submitter":["Huang ST"],"pubmed_abstract":["<h4>Background</h4>Longitudinal trajectories of healthcare utilization, medication prescription, and clinical outcomes among older adults with disabilities receiving home healthcare (HHC) holds significance but remains elusive.<h4>Methods</h4>People aged≥65 years who newly received Taiwan's National Health Insurance funded HHC program from January 2005 to December 2013 were identified. Healthcare utilization, life-sustaining treatment, medication prescriptions (polypharmacy, psychotropics, anticholinergic burden and antibiotics), health status (Charlson's comorbidity index, CCI), and mortality were assessed over a 10-year period spanning 5 years before and after initiating HHC.<h4>Results</h4>Overall, 187,547 patients (80.6 ± 7.7 years, 51.2 % females, CCI 3+: 51.2 %) with a high prevalenc"],"journal":["The Journal of frailty & aging"],"pagination":["100063"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC12399232"],"repository":["biostudies-literature"],"pubmed_title":["Healthcare utilization, pharmacotherapy prescriptions, and clinical outcomes across a 5-year duration preceding and succeeding the initiation of home health care in a nationwide population-based cohort of 187,547 older adults with disabilities."],"pmcid":["PMC12399232"],"pubmed_authors":["Hsiao FY","Liang CK","Huang ST","Lin CS","Lee WJ","Chou MY","Chen LK","Loh CH"],"additional_accession":[]},"is_claimable":false,"name":"Healthcare utilization, pharmacotherapy prescriptions, and clinical outcomes across a 5-year duration preceding and succeeding the initiation of home health care in a nationwide population-based cohort of 187,547 older adults with disabilities.","description":"<h4>Background</h4>Longitudinal trajectories of healthcare utilization, medication prescription, and clinical outcomes among older adults with disabilities receiving home healthcare (HHC) holds significance but remains elusive.<h4>Methods</h4>People aged≥65 years who newly received Taiwan's National Health Insurance funded HHC program from January 2005 to December 2013 were identified. Healthcare utilization, life-sustaining treatment, medication prescriptions (polypharmacy, psychotropics, anticholinergic burden and antibiotics), health status (Charlson's comorbidity index, CCI), and mortality were assessed over a 10-year period spanning 5 years before and after initiating HHC.<h4>Results</h4>Overall, 187,547 patients (80.6 ± 7.7 years, 51.2 % females, CCI 3+: 51.2 %) with a high prevalenc","dates":{"release":"2025-01-01T00:00:00Z","publication":"2025 Aug","modification":"2026-05-29T05:04:24.805Z","creation":"2026-04-08T03:44:53.294Z"},"accession":"S-EPMC12399232","cross_references":{"pubmed":["40608512"],"doi":["10.1016/j.tjfa.2025.100063"]}}